(-0.01%) 5 469.01 points
(0.11%) 39 153 points
(0.26%) 17 763 points
(0.06%) $80.88
(-5.04%) $2.62
(-0.80%) $2 312.10
(-0.13%) $28.83
(3.28%) $1 018.80
(0.34%) $0.936
(0.74%) $10.68
(0.50%) $0.792
(-0.28%) $87.25
0.50% $ 2.00
Live Chart Being Loaded With Signals
CytoMed Therapeutics Limited, a pre-clinical biopharmaceutical company, focuses on developing novel cell-based immunotherapies for the treatment of human cancers...
Stats | |
---|---|
Volumen de hoy | 85 |
Volumen promedio | 4 572 |
Capitalización de mercado | 23.08M |
EPS | $-0.130 ( Q4 | 2023-12-31 ) |
Próxima fecha de ganancias | ( $0 ) 2024-07-22 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-6.90 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0 (0.00%) |
CytoMed Therapeutics Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
CytoMed Therapeutics Finanzas
Annual | 2023 |
Ingresos: | $507 735 |
Beneficio Bruto: | $504 007 (99.27 %) |
EPS: | $-0.390 |
FY | 2023 |
Ingresos: | $507 735 |
Beneficio Bruto: | $504 007 (99.27 %) |
EPS: | $-0.390 |
FY | 2022 |
Ingresos: | $363 912 |
Beneficio Bruto: | $355 192 (97.60 %) |
EPS: | $-0.410 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
CytoMed Therapeutics
CytoMed Therapeutics Limited, a pre-clinical biopharmaceutical company, focuses on developing novel cell-based immunotherapies for the treatment of human cancers. The company\'s lead product candidate is CTM-N2D, which consists of expanded gamma delta T cells grafted with natural killer group 2D ligands-targeting chimeric antigen receptor to improve anti-cancer cytotoxicity. It is also developing iPSC-gdNKT, which utilizes iPSC as a starting material to generate gdNKT, a synthetic hybrid of a gamma delta T cell and a NK cell; and CTM-GDT, a product candidate that consists of expanded gamma delta T cells, and exploits the multiple recognition system of gamma delta T cell to recognize and treat a range of cancers. The company was incorporated in 2018 and is headquartered in Singapore.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico